ophthelmic prepartion
TRANSCRIPT
PREPARED BY :- BHASKAR DEWANGAN
B. Pharmacy University Institute Of PharmacyPt. R. S. University, Raipur(C.G.)
OPHTHALMIC SOLUTIONS
AND SUSPENSIONS
OBJECT
CONTENTS Ophthalmic drug delivery Pharmaceutic requirements Packaging ophthalmic solutions and
suspensions Proper administration of ophthalmic
solutions and suspensions
OPHTHALMIC DRUG DELIVERY
infectionsallergic or inflammation
elevated intraocular pressuredry-eye
PHARMACEUTIC REQUIREMENTSSpecial consideration for ophthalmic
preparations: sterility preservation isotonicity buffering viscosity ocular bioavailability and packaging
STERILITY AND PRESERVATION Ophthalmic solutions/suspensions could
be sterilized by- autoclaving at 121C for 15 minutes- bacterial filters
To maintain sterility during patient use, antimicrobial preservatives generally are included in ophthalmic formulations.
The preservatives used in ophthalmic solutions/suspensions are
benzalkonium chloride , 0.004-0.01%; benzethonium chloride, 0.01%; chlorobutanol, 0.5%; phenylmercuric acetate, 0.004%; phenylmercuric nitrite, 0.004%; thimerosal, 0.005-0.01%
ISOTONICITY VALUE Isotonic solution: a solution that has the
same salt concentration as the normal cells of the body and the blood.
Hypotonic, solutions with a lower osmotic pressure than body fluids or a 0.9% sodium chloride solution are commonly referred to as hypotonic.
Hypertonic, solutions have a greater osmotic pressure are termed hypertonic.
Boric acid has a molecular weight of 61.8, and thus 61.8 g in 1000 g of water should produce a freezing point of -1.86C. therefore:
1.86(C )/0.52(C )=61.8 (g)/x(g)X=17.3 g
17.3 g of boric acid in 1000g of water theoretically should produce a solution isosmotic with tears and blood.
BUFFERING The aims for adjusting the pH of an ophthalmic preparation:
for greater comfort to the eye; to render the formulation more stable; to enhance the aqueous solubility of the
drug; to enhance the drug’s bioavailability; to maximize preservative efficacy.
The pH of normal tears is considered to be about 7.4.
For maximum comfort, an ophthalmic solution should have the same pH as the lacrimal fluid.
A compromise pH is generally selected for solution and maintained by buffers to permit the greatest activity while maintaining stability.
VISCOSITY AND THICKENING AGENTS Viscosity for ophthalmic solutions is
considered optimal in the range of 15 to 25 cps.
In the preparation of ophthalmic solutions, a suitable grade of methylcellulose or other thickening agent (hydroxypropyl methylcellulose, polyvinyl alcohol) is frequently added to increase the viscosity.
OCULAR BIOAVAILABILITY
There are physiologic factors which can affect a drug’s ocular bioavailability, including
protein binding, drug metabolism lacrimal drainage
Tears contain0.6-2.0% of proteinTears containenzymes
PACKAGING OPHTHALMIC SOLUTIONS AND SUSPENSIONS
Soft plastic containers
2, 2.5, 5, 10, 15, 30 mL
PROPER ADMINISTRATION OF OPHTHALMIC SOLUTIONS AND SUSPENSIONS
wash hands thoroughly inspect for color and clarity be shaken thoroughly prior to
administration (ophthalmic suspensions)
not to touch the dropper to the eye, eyelid or any other surface
BIBLIOGRAPHY;-www.pharmatechnologyindex.comwww.visongain.comwww.jpionline.orgwww.biopharminternational.comwww.avonex.comwww.ondrugdelivery.comwww.bd.comwww.ec21.comwww.harikrushnatechnopride.tradeindia.comwww.pharmtech.comwww.baxterbiopharmasolutions.com
THANK YOU